Zoetis

The state-of-the-art facility in Tullamore, completed by PJ Hegarty, will house production lines for Zoetis’ biological therapeutics and monoclonal antibodies (mAbs), marking a fourfold increase in the site’s manufacturing capacity.
This project encompassed a range of Civil, Structural, and Architectural (CSA) design and construction elements. It featured an 8510m² single-story biopharmaceutical manufacturing facility, including state-of-the-art laboratory and office spaces. Additionally, the development saw the construction of a mezzanine plant room, a new 150-space car park, a sprinkler pump house, a medium voltage ESB substation, and external utility yards.